A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.
about
Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.Circulating microRNAs as Potential Biomarkers of Infectious Disease.Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward "precision" cancer therapy.A prognostic 4-gene expression signature for patients with HER2-negative breast cancer receiving taxane and anthracycline-based chemotherapy.Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.Transcriptional profiling of human neural precursors post alcohol exposure reveals impaired neurogenesis via dysregulation of ERK signaling and miR-145.Circular RNA Complement Factor H (CFH) Promotes Glioma Progression by Sponging miR-149 and Regulating AKT1
P2860
Q33838622-381DDF4E-AF2F-44F2-8FB1-78B6BE0C61D0Q33889001-7CB8F7AD-C91C-40E3-9A30-F88CB8204D03Q37643903-09E6AA89-0297-4965-8755-3F5A943367D0Q39187437-66C1B3E8-C832-4C9F-9711-3EBD9317D9CAQ47096783-E907562D-F6AE-419A-9549-081B2D519605Q47147014-054623BE-9454-4373-89D7-556F88DB341AQ47916776-B6866960-B8FD-4787-9E2C-D770DC8D7BEDQ58773484-FC14F6F3-0CEC-4EE7-B593-B1B5A323B953
P2860
A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A miRNA-based signature predic ...... t trastuzumab-based treatment.
@en
A miRNA-based signature predic ...... t trastuzumab-based treatment.
@nl
type
label
A miRNA-based signature predic ...... t trastuzumab-based treatment.
@en
A miRNA-based signature predic ...... t trastuzumab-based treatment.
@nl
prefLabel
A miRNA-based signature predic ...... t trastuzumab-based treatment.
@en
A miRNA-based signature predic ...... t trastuzumab-based treatment.
@nl
P2093
P2860
P356
P1433
P1476
A miRNA-based signature predic ...... t trastuzumab-based treatment.
@en
P2093
P2860
P2888
P356
10.1038/SREP33825
P407
P577
2016-09-21T00:00:00Z